No reason to reconsider HIF-2 as an oncogene in neuroblastoma and other cancer forms

Sofie Mohlin, Kristoffer Von Stedingk, Alexander Pietras, Sven Påhlman

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	E10856-E10858
Journal	Proceedings of the National Academy of Sciences of the United States of America
Volume	114
Issue number	51
DOIs	https://doi.org/10.1073/pnas.1716644115
Publication status	Published - 2017 Dec 19

Subject classification (UKÄ)

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{24827eff6f724ade9ceaa6e3950bdbb9,

title = "No reason to reconsider HIF-2 as an oncogene in neuroblastoma and other cancer forms",

author = "Sofie Mohlin and {Von Stedingk}, Kristoffer and Alexander Pietras and Sven P{\aa}hlman",

year = "2017",

month = dec,

day = "19",

doi = "10.1073/pnas.1716644115",

language = "English",

volume = "114",

pages = "E10856--E10858",

journal = "Proceedings of the National Academy of Sciences of the United States of America",

issn = "0027-8424",

publisher = "National Academy of Sciences",

number = "51",

}

TY - JOUR

T1 - No reason to reconsider HIF-2 as an oncogene in neuroblastoma and other cancer forms

AU - Mohlin, Sofie

AU - Von Stedingk, Kristoffer

AU - Pietras, Alexander

AU - Påhlman, Sven

PY - 2017/12/19

Y1 - 2017/12/19

U2 - 10.1073/pnas.1716644115

DO - 10.1073/pnas.1716644115

M3 - Letter

C2 - 29233939

AN - SCOPUS:85038611208

SN - 0027-8424

VL - 114

SP - E10856-E10858

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

IS - 51

ER -